Why Timely Referrals Are Vital for Heart Failure Patients
Doctors caution that successful outcomes could depend on how early patients are referred to a specialist for advanced therapies.
August 27, 2020 2:49 PM
Jane Racey Gleeson
Jane Racey Gleeson has been a member of the University of Michigan Frankel Cardiovascular Center’s communications team as a contributing writer for the past five years. She works with the team to produce targeted communications for a variety of Frankel CVC-related projects. Gleeson’s 30+ years in the technical communications field extends to custom publications, website development and integrated marketing for a variety of clients. She holds a bachelor’s degree in journalism from Oakland University in Rochester, Michigan.
Jugular Vein Aneurysm Considered Extremely Rare but Treatable
One patient had no discomfort associated with a rare aneurysm on her jugular vein — until a rupture required immediate surgery.
January 19, 2017 7:00 AM
Watchman or Warfarin? Choosing a Method of Stroke Prevention
Could a tiny device designed to avert stroke-provoking clots be a substitute for medication? The technology is an option for certain at-risk patients.
April 18, 2016 8:00 AM
A Tough Surgery with a ‘Transformative Impact’ for CTEPH
For those with a rare form of blood clots called CTEPH, a complex surgery is often the fix when medication fails. A U-M cardiac surgeon speaks about the procedure.
April 07, 2016 8:00 AM
More Authors
Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
